Tag

The Federal Reserve’s decision to delay an interest rate increase last week was largely a “risk management” exercise to be sure recent market volatility would not become a drag on the economy, Atlanta Fed President Dennis Lockhart said on Monday.

In early trading indications, shares were up 6.4% to $116.00.

Britain’s competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent.

Pfizer’s second quarter results surpassed expectations with the company beating on both the top- and bottom-line. Sales of the Prevnar 13 vaccine to prevent pneumococcal bacteria contributed $1.5 billion in revenues, up 37 per cent from the year-ago period.

Our second-quarter and year-to-date financial performance is the result of continued business momentum, driven by solid execution of recent product launches in our Innovative Products business …